S100A8 and acute myeloid leukemia: Even though S100A8 is a granulocyte maturation marker and not expressed in normal bone marrow CD34+ HSCs, Nicolas et al. showed, in a retrospective study, that BM MNCs of AML patients have elevated levels of S100A8 as a predictor of low survival [46].